Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss

Articles From: AxoGen, Inc. Announces Presentation of Avance(R) Nerve Graft Data at American Association of Plastic Surgeons 2013 Annual Meeting to Azteca Acquisition Corporation Sets Record Date for Special Meetings of Stockholders to Approve Merger with Cine Latino, Inc. and InterMedia Español Holdings, LLC and of Public Warrantholders to Approve Amendment of Warrants

This site contains about 74,006 documents.
View by:
Title  |  Date  |  Author  |  Collection  |  Interest  |  Popularity
Page:   1   130   140   150   160   170   180   190   200   210   222   223   224   225   226   227   228   229   230   231   232   233   234   235   236   237   238   239   240   241   242   243   244   245   246   247   248   249   250   251   260   270   280   290   300   310   320   330   400   500   600   700   800   900   1,000   1,100   1,200   2,000   2,467 

2013/4/19
AxoGen, Inc. Announces Presentation of Avance(R) Nerve Graft Data at American Association of Plastic Surgeons 2013 Annual Meeting
ALACHUA, Fla., April 19, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (OTCBB:AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today the presentation of two posters submitted by study investigators based on clinical use of Avance® Nerve Graft at the American Association of Plastic Surgeons (AAPS) Annual Meeting, being held April 20-23, 2013 in New Orleans, LA.
View more AxoGen, Inc. Announces Presentation of Avance(R) Nerve Graft Data at American Association of Plastic Surgeons 2013 Annual Meeting analysis
Sign-up for AxoGen, Inc. Announces Presentation of Avance(R) Nerve Graft Data at American Association of Plastic Surgeons 2013 Annual Meeting investment picks
2013/5/29
AxoGen, Inc. Announces Presentation of Avance(R) Nerve Graft Data at the 18th Federation of European Societies for Surgery of the Hand Congress
ALACHUA, Fla., May 29, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (OTCBB:AXGN) , a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that positive data based on clinical use of Avance® Nerve Graft will be presented in an oral presentation at the 18th Federation of European Societies for Surgery of the Hand (FESSH) Congress, May 29 to June 1, 2013 in Antalya, Turkey.
View more AxoGen, Inc. Announces Presentation of Avance(R) Nerve Graft Data at the 18th Federation of European Societies for Surgery of the Hand Congress analysis
Sign-up for AxoGen, Inc. Announces Presentation of Avance(R) Nerve Graft Data at the 18th Federation of European Societies for Surgery of the Hand Congress investment picks
2013/2/27
AxoGen, Inc. Announces Release Date of 2012 Fourth Quarter & Year End Results and Conference Call
AxoGen, Inc. (OTCBB: AXGN) , a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that it will release its financial results for the period ended December 31, 2012, after the close of U.S. financial markets on March 12, 2013.
View more AxoGen, Inc. Announces Release Date of 2012 Fourth Quarter & Year End Results and Conference Call analysis
Sign-up for AxoGen, Inc. Announces Release Date of 2012 Fourth Quarter & Year End Results and Conference Call investment picks
2013/4/24
AxoGen, Inc. Announces Release Date of First Quarter 2013 Results and Conference Call
ALACHUA, Fla., April 24, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (OTCBB:AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced that it will release its financial results for the period ended March 31, 2013, after the close of U.S. financial markets on April 30, 2013.
View more AxoGen, Inc. Announces Release Date of First Quarter 2013 Results and Conference Call analysis
Sign-up for AxoGen, Inc. Announces Release Date of First Quarter 2013 Results and Conference Call investment picks
2013/3/5
AxoGen, Inc. Appoints Shawn McCarrey as Senior Vice President of Sales
ALACHUA, Fla., March 5, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (OTCBB:AXGN) , a leader in the science and commercialization of surgical solutions for peripheral nerve repair, announced today the appointment of Shawn McCarrey to the position of Senior Vice President of Sales, effective immediately.
View more AxoGen, Inc. Appoints Shawn McCarrey as Senior Vice President of Sales analysis
Sign-up for AxoGen, Inc. Appoints Shawn McCarrey as Senior Vice President of Sales investment picks
2013/5/14
AxoGen, Inc. Files Form S-1 Registration Statement
ALACHUA, Fla., May 14, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (OTCBB:AXGN) (the "Company" or "AxoGen"), a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed $15 million underwritten public offering of shares of its common stock, subject to market and other conditions.
View more AxoGen, Inc. Files Form S-1 Registration Statement analysis
Sign-up for AxoGen, Inc. Files Form S-1 Registration Statement investment picks
2013/5/23
AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense
ALACHUA, Fla., May 23, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (OTCBB: AXGN) , a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today announced that the Company and Vanderbilt University have been awarded a shared $1.1 million grant, for which AxoGen's portion is approximately 35%, from the Congressional Directed Medical Research Programs administrated by the U.S. Department of Defense (DoD) to support the development and expansion of nerve repair technologies.
View more AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense analysis
Sign-up for AxoGen, Inc. Receives Grant in Partnership with Vanderbilt University from U.S. Department of Defense investment picks
2013/4/30
AxoGen, Inc. Reports First Quarter 2013 Financial Results
ALACHUA, Fla., April 30, 2013 (GLOBE NEWSWIRE) -- via PRWEB - First Quarter 2013 Highlights: AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced financial results for the first quarter ended March 31, 2013.
View more AxoGen, Inc. Reports First Quarter 2013 Financial Results analysis
Sign-up for AxoGen, Inc. Reports First Quarter 2013 Financial Results investment picks
2013/3/12
AxoGen, Inc. Reports Record 2012 Revenues
AxoGen, Inc. (OTCBB: AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, today reported revenues for the year ended December 31, 2012 of $7.69 million, a 59% increase over the $4.85 million reported during the same period in 2011.
View more AxoGen, Inc. Reports Record 2012 Revenues analysis
Sign-up for AxoGen, Inc. Reports Record 2012 Revenues investment picks
2013/3/18
AxoGen, Inc. to Highlight Products at the American Academy of Orthopedic Surgeons 2013 Meeting
ALACHUA, Fla., March 18, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc .
View more AxoGen, Inc. to Highlight Products at the American Academy of Orthopedic Surgeons 2013 Meeting analysis
Sign-up for AxoGen, Inc. to Highlight Products at the American Academy of Orthopedic Surgeons 2013 Meeting investment picks
2013/4/16
AxoGen, Inc. to Host Panel on Nerve Repair at the American College of Oral and Maxillofacial Surgeons 2013 Annual Meeting
ALACHUA, Fla., April 16, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (OTCBB:AXGN) a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that it is sponsoring a panel discussion on nerve repair and protection at the American College of Oral and Maxillofacial Surgeons (ACOMS) 2013 Annual Scientific Conference and Exhibition.
View more AxoGen, Inc. to Host Panel on Nerve Repair at the American College of Oral and Maxillofacial Surgeons 2013 Annual Meeting analysis
Sign-up for AxoGen, Inc. to Host Panel on Nerve Repair at the American College of Oral and Maxillofacial Surgeons 2013 Annual Meeting investment picks
2013/4/3
AxoGen, Inc. to Participate in Educational Symposium at American Association of Tissue Banks 2013 Spring Meeting
ALACHUA, Fla., April 3, 2013 (GLOBE NEWSWIRE) -- via PRWEB - AxoGen, Inc. (OTCBB: AXGN) , a leading regenerative medicine company focused on the commercialization of proprietary products and technologies for peripheral nerve reconstruction and regeneration, announced today that it will be participating in the American Association of Tissue Banks (AATB) 2013 Spring Meeting, April 6-9 in Tucson, Arizona.
View more AxoGen, Inc. to Participate in Educational Symposium at American Association of Tissue Banks 2013 Spring Meeting analysis
Sign-up for AxoGen, Inc. to Participate in Educational Symposium at American Association of Tissue Banks 2013 Spring Meeting investment picks
2013/3/13
Axsun Technologies to Present New Products at the 2013 OFC/NFOEC Exhibition
BILLERICA, Mass.
View more Axsun Technologies to Present New Products at the 2013 OFC/NFOEC Exhibition analysis
Sign-up for Axsun Technologies to Present New Products at the 2013 OFC/NFOEC Exhibition investment picks
2013/2/25
AXT, Inc. Announces $6 Million Stock Repurchase Program
http://media.marketwire.com/attachments/201301/55853_axtinclogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=989959&ProfileId=051205&sourceType=1 FREMONT, CA --
View more AXT, Inc. Announces $6 Million Stock Repurchase Program analysis
Sign-up for AXT, Inc. Announces $6 Million Stock Repurchase Program investment picks
2013/5/1
AXT, Inc. Announces First Quarter 2013 Financial Results
http://media.marketwire.com/attachments/201305/60623_axtinc.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1012910&ProfileId=051205&sourceType=1 FREMONT, CA --
View more AXT, Inc. Announces First Quarter 2013 Financial Results analysis
Sign-up for AXT, Inc. Announces First Quarter 2013 Financial Results investment picks
2013/2/25
AXT, Inc. Announces Fourth Quarter and Fiscal 2012 Financial Results
http://media.marketwire.com/attachments/201301/55853_axtinclogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=989924&ProfileId=051205&sourceType=1 FREMONT, CA --
View more AXT, Inc. Announces Fourth Quarter and Fiscal 2012 Financial Results analysis
Sign-up for AXT, Inc. Announces Fourth Quarter and Fiscal 2012 Financial Results investment picks
2013/3/7
AXT, Inc. Announces ISO/TS 16949 Certification
http://media.marketwire.com/attachments/201301/55853_axtinclogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=994048&ProfileId=051205&sourceType=1 FREMONT, CA --
View more AXT, Inc. Announces ISO/TS 16949 Certification analysis
Sign-up for AXT, Inc. Announces ISO/TS 16949 Certification investment picks
2013/5/2
AXT, Inc. Announces Upcoming Conference Participation
http://media.marketwire.com/attachments/201305/60623_axtinc.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1013526&ProfileId=051205&sourceType=1 FREMONT, CA --
View more AXT, Inc. Announces Upcoming Conference Participation analysis
Sign-up for AXT, Inc. Announces Upcoming Conference Participation investment picks
2013/4/2
AXT, Inc. Schedules First Quarter 2013 Earnings Release for May 1, 2013
http://media.marketwire.com/attachments/201301/55853_axtinclogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1002599&ProfileId=051205&sourceType=1 FREMONT, CA --
View more AXT, Inc. Schedules First Quarter 2013 Earnings Release for May 1, 2013 analysis
Sign-up for AXT, Inc. Schedules First Quarter 2013 Earnings Release for May 1, 2013 investment picks
2013/5/8
AYI Launches Native Android Application and Integrates Friend of Friends Feature into iPhone Application
NEW YORK , May 8, 2013 /PRNewswire/ -- Snap Interactive, Inc. (OTCBB: STVI) , is excited to announce the launch of the AYI native Android® application along with integration of the popular Friends of Friends feature on AYI's mobile-web and iPhone® application.
View more AYI Launches Native Android Application and Integrates Friend of Friends Feature into iPhone Application analysis
Sign-up for AYI Launches Native Android Application and Integrates Friend of Friends Feature into iPhone Application investment picks
2013/5/6
AZ Sint-Jan Brugge Hospital Offers Innovative Care with Real-Time Image-Guided Surgery Through Polycom Video Collaboration Solutions
Polycom , Inc. (Nasdaq: PLCM) , the global leader in open, standards-based unified communications and collaboration (UC&C), today announced that AZ Sint-Jan Brugge Hospital (Belgium) has equipped five new state-of-the-art digital operating rooms with secure, Polycom® RealPresence® video collaboration solutions.
View more AZ Sint-Jan Brugge Hospital Offers Innovative Care with Real-Time Image-Guided Surgery Through Polycom Video Collaboration Solutions analysis
Sign-up for AZ Sint-Jan Brugge Hospital Offers Innovative Care with Real-Time Image-Guided Surgery Through Polycom Video Collaboration Solutions investment picks
2013/6/4
Azerbaijan Signs $1 Billion Submersible Drilling Rig Deal
BAKU, Azerbaijan --A company owned by Azerbaijan's state-run oil company, Socar, signed a $1 billion deal Tuesday with a division of Singapore's Keppel Corp.
View more Azerbaijan Signs $1 Billion Submersible Drilling Rig Deal analysis
Sign-up for Azerbaijan Signs $1 Billion Submersible Drilling Rig Deal investment picks
2013/4/8
AZH Issues Convertible Notes / Appendix 3B
AZH Issues Convertible Notes / Appendix 3B Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES ./ PERTH , Australia , April 8, 2013 /CNW/ - Azimuth Resources Limited (ASX and TSX: AZH) (the " Company " or " Azimuth ") is pleased to announce it has today issued convertible notes to Troy Resources Limited for consideration of $10,000,000 , on the terms set out in the announcement dated 28 March 2013 .
View more AZH Issues Convertible Notes / Appendix 3B analysis
Sign-up for AZH Issues Convertible Notes / Appendix 3B investment picks
2013/6/6
Azimuth Resources - Update on Troy Takeover Offer
Azimuth Resources - Update on Troy Takeover Offer Canada NewsWire Dear Azimuth Shareholder, We are pleased to advise you that as at the close of business on 6 June 2013 , acceptances of Troy Resources Limited's takeover offer for Azimuth Resources Limited stood at 37.99%, comprising direct acceptances and shares lodged into the Institutional Acceptance Facility.
View more Azimuth Resources - Update on Troy Takeover Offer analysis
Sign-up for Azimuth Resources - Update on Troy Takeover Offer investment picks
2013/4/14
Azimuth Resources Limited - Cancellation of Unlisted Options
Azimuth Resources Limited - Cancellation of Unlisted Options Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES ./ PERTH , Australia , April 15, 2013 /CNW/ - Azimuth Resources Limited (ASX and TSX: AZH) (the "Company" or "Azimuth") advises it has today cancelled the following unlisted options issued under the Company's Employees and Consultants Option Plan.
View more Azimuth Resources Limited - Cancellation of Unlisted Options analysis
Sign-up for Azimuth Resources Limited - Cancellation of Unlisted Options investment picks
2013/5/17
Azimuth Resources Limited - Supplementary Target's Statement
Azimuth Resources Limited - Supplementary Target's Statement Canada NewsWire PERTH , Australia , May 17, 2013 /CNW/ - Azimuth Resources Limited (ABN 87 089 531 082) ( Azimuth ) (ASX, TSX: AZH) has released, under section 644 of the Corporations Act 2001 (Cth), a Supplementary Target's Statement, dated 17 May 2013 which is supplementary to Azimuth's Target's Statement dated 9 May 2013 in relation to the off-market takeover bid by Troy Resources Limited (ABN 33 006 243 750) (ASX, TSX: TRY) ( Troy ) for all the ordinary shares in Azimuth ( Offer ). This supplementary target's statement dated 17 May 2013 has been given to each of the Australian Securities & Investments Commission and Troy today and will be filed on the Canadian System for Electronic Document Analysis and Retrieval ("SEDAR") today.
View more Azimuth Resources Limited - Supplementary Target's Statement analysis
Sign-up for Azimuth Resources Limited - Supplementary Target's Statement investment picks
2013/5/20
Azlan Named Finalist in 2013 Comms Dealer Sales Awards for Data-Driven Marketing Campaign Powered by MaintenanceNet
http://media.marketwire.com/attachments/200607/273119_MN-RBGweb.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1019055&ProfileId=051205&sourceType=1 LONDON --
View more Azlan Named Finalist in 2013 Comms Dealer Sales Awards for Data-Driven Marketing Campaign Powered by MaintenanceNet analysis
Sign-up for Azlan Named Finalist in 2013 Comms Dealer Sales Awards for Data-Driven Marketing Campaign Powered by MaintenanceNet investment picks
2013/4/2
Azteca Acquisition Corporation Announces Receipt of Votes of 75.5% of Outstanding Shares in Favor of Merger Proposal; Extension of Redemption Deadline to April 3, 2013
Azteca Acquisition Corporation (OTCBB: AZTA; AZTAW; AZTAU) (“Azteca”) announced today the extension of Azteca stockholders’ right to redeem their shares for cash to April, 3, 2013, by complying with the requirements set forth in the proxy statement/prospectus related to the proposed merger and warrant amendment (the “Proxy Statement”). As previously disclosed in the Proxy Statement, Hemisphere Media Group, Inc. “Hemisphere”) has applied to list its shares of Class A common stock on The Nasdaq Stock Market (“NASDAQ”) under the symbol “HMTV”. Hemisphere has been informed by NASDAQ that it has not yet satisfied the requisite round lot holder requirement necessary for listing on NASDAQ immediately following the closing.
View more Azteca Acquisition Corporation Announces Receipt of Votes of 75.5% of Outstanding Shares in Favor of Merger Proposal; Extension of Redemption Deadline to April 3, 2013 analysis
Sign-up for Azteca Acquisition Corporation Announces Receipt of Votes of 75.5% of Outstanding Shares in Favor of Merger Proposal; Extension of Redemption Deadline to April 3, 2013 investment picks
2013/3/18
Azteca Acquisition Corporation Sets Date for Special Meetings of Stockholders to Approve Merger with Cine Latino, Inc. and InterMedia Español Holdings, LLC and of Public Warrantholders to Approve Amendment of Warrants
Azteca Acquisition Corporation (OTCBB: AZTA; AZTAW; AZTAU) (“Azteca”) announced today that the special meeting of its stockholders to approve its previously announced merger (the “Azteca Merger Proposal”) with Cine Latino, Inc. (“Cinelatino”) and InterMedia Español Holdings, LLC (“WAPA”) and the special meeting of its public warrantholders to approve the amendment of certain terms of its warrants, will be held on April 4, 2013, at 9:30 a.m. and 9:00 a.m., Eastern Time, respectively, at the offices of Greenberg Traurig, LLP, 200 Park Avenue, New York, New York.
View more Azteca Acquisition Corporation Sets Date for Special Meetings of Stockholders to Approve Merger with Cine Latino, Inc. and InterMedia Español Holdings, LLC and of Public Warrantholders to Approve Amendment of Warrants analysis
Sign-up for Azteca Acquisition Corporation Sets Date for Special Meetings of Stockholders to Approve Merger with Cine Latino, Inc. and InterMedia Español Holdings, LLC and of Public Warrantholders to Approve Amendment of Warrants investment picks
2013/2/28
Azteca Acquisition Corporation Sets Record Date for Special Meetings of Stockholders to Approve Merger with Cine Latino, Inc. and InterMedia Español Holdings, LLC and of Public Warrantholders to Approve Amendment of Warrants
Azteca Acquisition Corporation (OTCBB: AZTA; AZTAW; AZTAU) (“Azteca”) announced today that the record date for the special meeting of its stockholders to approve its previously announced merger with Cine Latino, Inc. (“Cinelatino”) and InterMedia Español Holdings, LLC (“WAPA”), the special meeting of its public warrantholders to approve the amendment of certain terms of its warrants and for any other purpose, will be March 10, 2013, as of 5:00 p.m. (the “Record Date”). Azteca’s stockholders and public warrantholders of record as of the Record Date will receive notice of and voting materials relating to these special meetings in the future.
View more Azteca Acquisition Corporation Sets Record Date for Special Meetings of Stockholders to Approve Merger with Cine Latino, Inc. and InterMedia Español Holdings, LLC and of Public Warrantholders to Approve Amendment of Warrants analysis
Sign-up for Azteca Acquisition Corporation Sets Record Date for Special Meetings of Stockholders to Approve Merger with Cine Latino, Inc. and InterMedia Español Holdings, LLC and of Public Warrantholders to Approve Amendment of Warrants investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
Articles From: AxoGen, Inc. Announces Presentation of Avance(R) Nerve Graft Data at American Association of Plastic Surgeons 2013 Annual Meeting to Azteca Acquisition Corporation Sets Record Date for Special Meetings of Stockholders to Approve Merger with Cine Latino, Inc. and InterMedia Español Holdings, LLC and of Public Warrantholders to Approve Amendment of Warrants
Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Mutual Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title
ETFs by:
Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name
Investment Categories by:
Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry
Premimum Stocks by:
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry
Premimum Funds by:
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title
Premimum ETFs by:
Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name
Popular Articles by:
Title |  Date |  Author |  Collection |  Popularity |  Interest
SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Popular SEC Filings by:
Title |  Date |  Company |  Symbol |  Interest |  Popularity
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.